• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy.

作者信息

Franchini Massimo, Marano Giuseppe, Velati Claudio, Pati Ilaria, Pupella Simonetta, Maria Liumbruno Giancarlo

机构信息

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.

出版信息

Vox Sang. 2021 Jan;116(1):136-137. doi: 10.1111/vox.12940. Epub 2020 May 17.

DOI:10.1111/vox.12940
PMID:32324899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7264735/
Abstract
摘要

相似文献

1
Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy.意大利新冠康复者恢复期血浆捐献操作流程
Vox Sang. 2021 Jan;116(1):136-137. doi: 10.1111/vox.12940. Epub 2020 May 17.
2
Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy.在一个中等收入经济体中开展和实施新冠康复者血浆项目。
Hematol Transfus Cell Ther. 2022 Apr-Jun;44(2):206-212. doi: 10.1016/j.htct.2022.01.001. Epub 2022 Jan 19.
3
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.恢复期血浆治疗 2019 冠状病毒病（COVID-19）：临床试验设计的考虑因素。
Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12.
4
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.一名63岁感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的女性，她发展为重症冠状病毒病2019（COVID-19）肺炎并接受了恢复期血浆治疗。
Am J Case Rep. 2020 Sep 29;21:e927662. doi: 10.12659/AJCR.927662.
5
A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.资源受限血液中心新型冠状病毒肺炎康复者血浆捐献者招募策略的前瞻性研究
ISBT Sci Ser. 2021 Nov;16(4):276-283. doi: 10.1111/voxs.12639. Epub 2021 Jun 1.
6
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.COVID-19 恢复期血浆捐献的安全性：一项多机构供者血液警戒研究。
Transfusion. 2021 Sep;61(9):2668-2676. doi: 10.1111/trf.16572. Epub 2021 Jul 6.
7
High-titre anti-SARS-CoV-2 convalescent plasma donation after donors' vaccination.供体接种疫苗后捐献的高滴度抗SARS-CoV-2康复期血浆
Vox Sang. 2021 Sep;116(8):930-931. doi: 10.1111/vox.13094. Epub 2021 Mar 21.
8
Antibody response against SARS-CoV-2 in convalescent plasma donors: Can we predict subjects' eligibility?康复期血浆捐献者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的抗体反应：我们能否预测受试者的合格性？
Hematol Transfus Cell Ther. 2022 Jan-Mar;44(1):1-6. doi: 10.1016/j.htct.2021.07.008. Epub 2021 Nov 4.
9
Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells.使用早期捐赠的新冠康复者血浆最有利于保持淋巴管内皮细胞的完整性。
Pharmaceuticals (Basel). 2022 Mar 17;15(3):365. doi: 10.3390/ph15030365.
10
Effectiveness and feasibility of convalescent blood transfusion to reduce COVID-19 fatality ratio.恢复期血浆输注降低新型冠状病毒肺炎病死率的有效性和可行性
R Soc Open Sci. 2021 Feb 10;8(2):202248. doi: 10.1098/rsos.202248.

引用本文的文献

1
Convalescent plasma for people with COVID-19: a living systematic review.COVID-19 患者恢复期血浆治疗：一项实时系统评价。
Cochrane Database Syst Rev. 2023 May 10;5(5):CD013600. doi: 10.1002/14651858.CD013600.pub6.
2
An update on SARS-CoV-2 immunization and future directions.新型冠状病毒2型免疫接种的最新情况及未来方向。
Front Pharmacol. 2023 Mar 9;14:1125305. doi: 10.3389/fphar.2023.1125305. eCollection 2023.
3
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update.用于COVID-19治疗的康复期血浆（高免疫球蛋白）：最新情况
Process Biochem. 2023 Apr;127:66-81. doi: 10.1016/j.procbio.2023.01.018. Epub 2023 Jan 31.
4
Convalescent plasma for people with COVID-19: a living systematic review.COVID-19 患者恢复期血浆治疗：一项实时系统评价。
Cochrane Database Syst Rev. 2023 Feb 1;2(2):CD013600. doi: 10.1002/14651858.CD013600.pub5.
5
Comparison of the Effects of Plasmapheresis, Hemoperfusion, and Convalescent Plasma Therapy on Inflammatory Factors in COVID-19 Patients.血浆置换、血液灌流和恢复期血浆治疗对COVID-19患者炎症因子影响的比较
Med J Islam Repub Iran. 2022 Nov 26;36:142. doi: 10.47176/mjiri.36.142. eCollection 2022.
6
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients.关注变异株-血清阴性住院患者使用匹配的 COVID-19 恢复期血浆。
Viruses. 2022 Jun 30;14(7):1443. doi: 10.3390/v14071443.
7
Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience.康复期血浆治疗住院COVID-19患者：单中心经验
Life (Basel). 2022 Mar 14;12(3):420. doi: 10.3390/life12030420.
8
Perplexing issues for convalescent immune plasma therapy in COVID-19.新冠康复期免疫血浆疗法面临的棘手问题。
North Clin Istanb. 2021 Nov 15;8(6):634-643. doi: 10.14744/nci.2021.73604. eCollection 2021.
9
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody.评估用于预测高滴度严重急性呼吸综合征冠状病毒2中和抗体的自动化高通量血清学检测方法。
J Clin Virol Plus. 2021 Jun;1(1):100016. doi: 10.1016/j.jcvp.2021.100016. Epub 2021 May 4.
10
Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies.基于荧光共振能量转移分析、对接和药效团研究，从色烯、黄酮类化合物和异羟肟酸化合物中筛选潜在的新型冠状病毒3C样蛋白酶抑制剂。
Results Chem. 2021 Jan;3:100195. doi: 10.1016/j.rechem.2021.100195. Epub 2021 Sep 20.

本文引用的文献

1
Convalescent plasma as a potential therapy for COVID-19.康复期血浆作为治疗新冠肺炎的一种潜在疗法。
Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.
2
Coronavirus Disease 2019: Coronaviruses and Blood Safety.2019 年冠状病毒病：冠状病毒与血液安全。
Transfus Med Rev. 2020 Apr;34(2):75-80. doi: 10.1016/j.tmrv.2020.02.003. Epub 2020 Feb 21.
3
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?严重急性呼吸综合征（SARS）、中东呼吸综合征（MERS）和新型冠状病毒（COVID-19）疫情，最新和最大的全球健康威胁：我们从中吸取了哪些教训？
Int J Epidemiol. 2020 Jun 1;49(3):717-726. doi: 10.1093/ije/dyaa033.
4
Potential interventions for novel coronavirus in China: A systematic review.中国新型冠状病毒潜在干预措施的系统评价。
J Med Virol. 2020 May;92(5):479-490. doi: 10.1002/jmv.25707. Epub 2020 Mar 3.